US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Latest News about Angelman syndrome

Recent news which mentions Angelman syndrome

Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
Tickers RARE
Tags General Phase 2 Trial Movers
From Benzinga